Surgical Oncology, the NRG-HN006 trial for early-stage oral cavity cancer, and patient language in protocols with Dr. Lai
The NRG Oncology PodcastShow Notes
Drs. Chun and Henke sit down with Dr. Stephen Lai, the NRG Oncology Surgical Oncology Committee Chair and the PI of the NRG-HN006 study of sentinel lymph node biopsy for early stage oral cavity disease. Dr. Lai addresses how surgical oncology fits within the NRG spectrum, his very important study that is actively enrolling patients, and his advocacy and passion for improving patient language on protocol documents.
More from The NRG Oncology Podcast
For Breast Cancer Awareness Month, we discuss the results of the NRG-BR002 in newly oligometastatic breast cancer published in the Journal of Clinical Oncology today.
We discuss the reported results of the NRG-HN009 p16-negative cohort presented at the ASTRO Annual Meeting Late-Breaking Abstract Session.
We discuss both the NRG-CC009 study results presented during the 2026 ASTRO Annual Meeting Plenary Session and the MAVERICK study results presented during the Clinical Trials Session.
We discuss the NRG-GI003 results presented during the 2026 ASTRO Annual Meeting Plenary Session.
We interview Dr. Shang "George" Zhao on the NRG-RTOG 0534 "SPPORT" study results he presented at the 2026 ASTRO Annual Meeting Clinical Trials Session.